Dashboard
Manage Tickers

STESTERIS plc

NYSE steris.com


$ 237.21 $ 0.64 (0.27 %)    

Wednesday, 28-Aug-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.16 $ -5.41 (-1.13 %)
DIA $ 411.36 $ -1.55 (-0.38 %)
SPY $ 558.32 $ -3.26 (-0.58 %)
TLT $ 97.88 $ -0.12 (-0.12 %)
GLD $ 231.76 $ -1.64 (-0.7 %)
$ 237.07
$ 235.78
$ 237.07 x 100
-- x --
$ 235.78 - $ 238.19
$ 194.58 - $ 243.37
355,625
na
23.38B
$ 0.94
$ 58.44
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-29-2024 03-31-2024 10-K
3 02-08-2024 12-31-2023 10-Q
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-26-2023 03-31-2023 10-K
7 02-08-2023 12-31-2022 10-Q
8 11-09-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-31-2022 03-31-2022 10-K
11 02-09-2022 12-31-2021 10-Q
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-28-2021 03-31-2021 10-K
15 02-09-2021 12-31-2020 10-Q
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-29-2020 03-31-2020 10-K
19 02-10-2020 12-31-2019 10-Q
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-30-2019 03-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
08/08/2024 10:23:31

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

evaluating-steris-insights-from-4-financial-analysts
Evaluating Steris: Insights From 4 Financi...
08/07/2024 21:00:57

jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target
JMP Securities Reiterates Market Outperfor...
08/07/2024 20:41:39

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

stephens--co-reiterates-overweight-on-steris-maintains-260-price-target
Stephens & Co. Reiterates Overweight on St...
08/07/2024 20:02:15

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $260 price target.

steris-continues-to-expect-as-reported-revenue-from-continuing-operations-to-increase-65-75-in-fiscal-2025-adjusted-eps-to-be-in-the-range-of-905-925-vs-914-est
STERIS Continues To Expect As Reported Rev...
08/06/2024 20:33:05

Fiscal 2025 Outlook Reiterated

steris-q1-adj-203-beats-198-estimate
Steris Q1 Adj $2.03 Beats $1.98 Estimate
08/06/2024 20:31:44

Steris (NYSE:STE) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.98 by 2.53 per...

jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target
JMP Securities Reiterates Market Outperfor...
07/26/2024 18:20:05

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

these-10-large-cap-stocks-shined-brightest-last-week-may-5-may-11-2024-are-they-in-your-portfolio
These 10 Large Cap Stocks Shined Brightest...
05/12/2024 17:33:47

Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in ...

piper-sandler-reiterates-neutral-on-steris-raises-price-target-to-225
Piper Sandler Reiterates Neutral on Steris...
05/10/2024 13:24:42

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Neutral and raises the price target from $220 to $225.

needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
05/10/2024 10:06:12

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target
JMP Securities Reiterates Market Outperfor...
05/09/2024 18:47:42

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

steris-expects-fy25-as-reported-revenue-from-continuing-operations-to-increase-65-75-adjusted-eps-from-continuing-operations-of-905---925-est-933
STERIS Expects FY25 As Reported Revenue Fr...
05/08/2024 21:13:04

Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 m...

steris-plans-restructuring-of-healthcare-surgical-business-in-europe-other-actions
STERIS Plans Restructuring Of Healthcare S...
05/08/2024 21:11:08

STERIS today is also announcing a targeted restructuring plan, which includes restructuring of the Healthcare surgical business...

steris-q4-2024-adj-eps-258-beats-235-estimate-sales-1419b-beat-1411b-estimate
Steris Q4 2024 Adj EPS $2.58 Beats $2.35 E...
05/08/2024 20:32:40

Steris (NYSE:STE) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.35 by 9.79 per...

needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
04/12/2024 08:39:39

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

steris-shares-are-trading-higher-after-the-company-entered-a-deal-to-divest-its-dental-segment-to-peak-rock-capital-for-7875-million
STERIS shares are trading higher after the...
04/11/2024 11:08:45

steris-enters-definitive-deal-to-divest-its-dental-segment-to-peak-rock-capital-for-7875m
STERIS Enters Definitive Deal To Divest It...
04/11/2024 10:59:43

The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an ad...

what-4-analyst-ratings-have-to-say-about-steris
What 4 Analyst Ratings Have To Say About S...
02/09/2024 19:01:14

stephens--co-reiterates-overweight-on-steris-maintains-250-price-target
Stephens & Co. Reiterates Overweight on St...
02/09/2024 18:12:54

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $250 price target.

jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target
JMP Securities Reiterates Market Outperfor...
02/08/2024 19:23:21

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION